Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BNK Venture Capital is a South Korea-based venture capital and private equity firm, established in 2009. It focuses on early-stage investments across various sectors, including new growth engine industries such as mobile phones, LCD TVs, and semiconductors. The company was formerly known as UQI Partners before being acquired by BNK Financial Group in 2019. There is no evidence that the firm specializes in life sciences, biotech, pharma, or healthcare investments[1][2][5][7].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BNK Venture Capital.